Figure 3 — ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility

Research Paper|Volume 15, Issue 13|pp. 6179–6211

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m⁶A modification, and drug susceptibility

Back to articleFigure 3(3 of 10)

100%

Figure 3.Box plots exploring the relationship between ZNF765 expression and clinicopathological characteristics. (A) Age; (B) Gender; (C) Grade; (D) Stage; (E) T (size of the tumor); (F) N (lymph node metastasis).